epistaxis. Epistaxis
Conditions
Interventions
Intervention 1: Intervention group: half percent timolol nasal spray manufactured by Raha Pharmaceutical Company, one puff in each nostril twice a day for 4 weeks. Intervention 2: Control group: Norma
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: History of recurrent epistaxis with at least 4 episodes in the last four weeks
Exclusion criteria
Exclusion criteria: Pregnancy Having bronchial asthma or chronic lung disease Suffering from diseases that cause coagulation problems, such as hemophilia Patients with low blood pressure Having pheochromocytoma or severe peripheral blood circulation disorders Receiving calcium antagonists History of nose surgery in the last month breastfeeding Having chronic lung disease Patients with heart failure Patients with bradycardia Patients with other cardiac contraindications for beta-blockers Patients with peripheral vascular circulation dysfunction Receiving amiodarone Receiving antiarrhythmics Receiving clonidine Receiving lidocaine Receiving beta blockers Receiving fluctafenine Receiving soltopride Hypersensitivity to timolol Use of anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Epistaxis. Timepoint: Before the intervention and 2 weeks, 4 weeks, and 8 weeks after the intervention. Method of measurement: History taking. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfrooz Eshaghian
Esfahan University of Medical Sciences
Outcome results
None listed